Retinoic acid redifferentiation therapy for thyroid cancer

Thyroid

Volumn 10, Issue 5, 2000, Pages 393-406

  Schmutzler, Cornelia ^a   Köhrle, Josef ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ANAPLASTIC CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYROID CANCER; TUMOR VOLUME;

EID: 1642633540     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.393     Document Type: Review

References (121)

1. Wolf G 1996 A history of vitamin A and retinoids. FASEB J 10:1102-1107.
2. Underwood BA, Arthur P 1996 The contribution of vitamin A to public health. FASEB J 10:1040-1048.
3. Hinds TS, West WL, Knight EM 1997 Carotenoids and Retinoids: A review of research, clinical, and public health applications. J Clin Pharmacol 37:551-558.
4. Langston AW, Thompson JR, Gudas LJ 1997 Retinoic acid-responsive enhancers located 3′ of the Hox A and Hox B homeobox gene clusters. J Biol Chem 272:2167-2175.
5. Hofman C, Eichele G 1994 Retinoids in development. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry, and Medicine. Raven Press Ltd., New York, p 387-441.
6. Means AL, Gudas LJ 1995 The roles of retinoids in vertebrate development. Annu Rev Biochem 64:201-233.
7. Niederreither K, Subbarayan V, Dolle P, Chambon P 1999 Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet 21:444-448.
8. Maden M, Gale E, Zile M 1998 The role of vitamin A in the development of the central nervous system. J Nutr 128: 471S-475S.
9. Lin RJ, Egan DA, Evans RM 1999 Molecular genetics of acute promyelocytic leukemia. Trends Genet 15:179-184.
10. Fisher GJ, Voorhees JJ 1996 Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013.
11. Van Pelt AMM, De Rooij DG 1990 Synchronization of the seminiferous epithelium after vitamin A replacement in vitamin-A-deficient mice. Biol Reprod 43:363-367.
12. Chytil F 1996 Retinoids in lung development. FASEB J 10:986-992.
13. Strickland S, Mahdavi V 1978 The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403.
14. Breitman TR, Selonick S, Collins SJ 1980 Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940.
15. Scheibe RJ, Ginty D, Wagner JA 1991 Retinoic acid stimulates the differentiation of PC12 cells that are deficient in cAMP-dependent protein kinase. J Cell Biol 113:1173-1181.
16. Haussler M, Sidell N, Kelly M, Donaldson C, Altman A, Mangelsdorf DJ 1983 Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines. Proc Natl Acad Sci USA 80:5525-5529.
17. Lotan R, Lotan D 1980 Stimulation of melanogenesis in a human melanoma cell line by retinoids. Cancer Res 40:3345-3350.
18. Safonova I, Darimont C, Amri E-Z, Grimaldi P, Ailhaud G, Reichert U, Shroot B 1994 Retinoids are positive effectors of adipose cell differentiation. Mol Cell Endocrinol 104:201-211.
19. Halevy O, Lerman O 1993 Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-α. J Cell Physiol 154:566-572.
20. Giguère V 1994 Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signalling. Endocr Rev 15:61-79.
21. Mangelsdorff DJ, Evans RE 1995 The RXR heterodimers and orphan receptors. Cell 86:841-850.
22. Beato M, Herrlich P, Schütz G 1995 Steroid hormone receptors: Many actors in search of a plot. Cell 83:851-857.
23. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C 1995 Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693.
24. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte proliferation. Cell 83:813-819.
25. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383:728-731.
26. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM 1999 Bile acids: Natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
27. Glass CK, Rose DW, Rosenfeld MG 1997 Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232.
28. Torchia J, Glass CK, Rosenfeld MG 1998 Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10:373-383.
29. Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai MJ, O'Malley BW 1993 Interaction of thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci 90:8832-8836.
30. Fanjul A, Dawson MI, Hobbs PD, Long L, Cameron JF, Harlev E, Graupner G, Lu X-P, Pfahl M 1994 A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 72:107-111.
31. Zhou X-F, Shen X-Q, Shemshedini L 1999 Ligand-Activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 13:276-285.
32. Karin M, Liu Z-G, Zandi E 1997 AP-1 function and regulation. Curr Opin Cell Biol 9:240-246.
33. Hong WK, Itri LM 1994 Retinoids and human cancer. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry, and Medicine. Raven Press Ltd., New York, p 597-630.
34. Chomienne C, Fenaux P, Degos L 1996 Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 10: 1025-1030.
35. Moon RC, Mehta RG, Rao KVN 1994 Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry, and Medicine. Raven Press Ltd., New York, p 573-595.
36. Lotan R 1996 Retinoids in cancer chemoprevention. FASEB J 10:1031-1039.
37. Lippman SM, Lotan R, Schleuniger U 1997 Retinoid-interferon therapy of solid tumours. Int J Cancer 70:481-483.
38. Braverman LE, Utiger RD (eds) 1996 Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, New York.
39. Wynford-Thomas D 1999 Molecular basis of tumors arising in thyroid follicular cells. Ann Chir 53:237-243.
40. Farid NR 1996 Molecular pathogenesis of thyroid cancer: The significance of oncogenes, tumor suppressor genes, and genomic instability. Exp Clin Endocrinol Diabetes 104 (Suppl 4):1-12.
41. Rochefort P, Caillou B, Michaels F-M, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J 1996 Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene 12:111-118.
42. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J, Hoffman L 1997 Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345-348.
43. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748.
44. Schlumberger MJ 1998 Papillary and Follicular Thyroid Carcinoma. N Engl J Med 338:297-306.
45. Mazzaferri EL 1999 An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421-427.
46. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Röher HD 1994 Surgical reintervention for differentiated thyroid carcinoma. Br J Surg 80:1131-1134.
47. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999 141:443-457.
48. Brabant G, Maenhaut C, Köhrle J, Scheumann G, Dralle H, Hoang-Vu C, Hesch RD, von zur Mühlen A, Vassart G, Dumont JE 1991 Human thyrotropin receptor gene: Expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7-R12.
49. Ain KB 1998 Anaplastic thyroid carcinoma: Behaviour, biology, and approaches. Thyroid 8:715-726.
50. Schmutzler C, Köhrle J 2000 Innovative strategies for the treatment of thyroid cancer. Eur J Endocrinol (in press).
51. Love JM, Gudas LJ 1994 Vitamin A, differentiation, and cancer. Curr Opin Cell Biol 6:825-831.
52. Schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner J, Simon D, Goretzki PE, Köhrle J 1998 Functional retinoid and thyroid hormone receptors in human thyroid cell lines and tissues. Int J Cancer 76:368-376.
53. Brtko J 1994 Accurate determination and physicochemical properties of rat liver nuclear retinoic acid (RA) receptors. Biochem Biophys Res Commun 204:439-445.
54. Jakobs TC, Schmutzler C, Meissner J, Köhrle J 1997 The promoter of the human type I 5′-deiodinase gene: Mapping of the transcription start site and identification of a DR+4 thyroid hormone responsive element. Eur J Biochem 247:288-297.
55. Del Senno L, Rossi R, Franceschetti P, degli Uberti EC 1994 Expression of all-trans-retinoic acid receptor RNA in human thyroid cells. Biochem Mol Biol Int 33:1107-1115.
56. Rochaix P, Monteil-Onteniente S, Rochette-Egly C, Caratero C, Voigt JJ, Jozan S 1998 Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: Immunohistochemical and western blot study. Histopathology 33:337-343.
57. Misiti S, Schomburg L, Yen PM, Chin WW 1998 Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139:2493-2500.
58. Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, Chambon P 1992 Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70:1007-1019.
59. Kastner P, Mark M, Chambon P 1995 Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83:859-869.
60. Köhrle J 1999 Local activation and inactivation of thyroid hormones: The deiodinase family. Mol Cell Endocrinol 151:103-119.
61. Schreck R, Schnieders F, Schmutzler C, Köhrle J 1994 Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab 79:791-798.
62. Schmutzler C, Brtko J, Bienert K, Köhrle J 1996 Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom. Exp Clin Endocrinol Metab 104(Suppl 4):16-19.
63. Lemoine NR, Mayall ES, Jones T, Sheer D, McDermid S, Kendall-Taylor P, Wynford-Thomas D 1989 Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer 60:898-903.
64. Zhang CY, Kim S, Harney JW, Larsen PR 1998 Further characterization of thyroid hormone response elements in the human type 1 iodothyronine deiodinase gene. Endocrinology 139:1156-1163.
65. Toyoda N, Zavacki AM, Maia AL, Harney JW, Larsen PR 1995 A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol 15:5100-5112.
66. Carrasco N 1993 Iodide transport in the thyroid gland. Biochim Biophys Acta 1154:65-82.
67. Levy O, De la Vieja A, Carrasco N 1998 The Na+/I-symporter (NIS): Recent advances. J Bioenerg Biomembr 30:195-206.
68. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460.
69. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226:339-345.
70. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM 1997 Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138:3555-3558.
71. Schmutzler C, Winzer R, Meissner-Weigl J, Köhrle J 1997 Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun 240:832-838.
72. Arturi F, Russo D, Schlumberger M, du Villard J-A, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG, Filetti S 1998 Iodide symporter gene expression in human thyroid rumors. J Clin Endocrinol Metab 83:2493-2496.
73. - symporter distribution in human thyroid tissues: An immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106.
74. Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL 1998 An immunohistochemical study of Na+/I-symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416-4419.
75. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC 1999 Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer. J Endocrinol 163:495-504.
76. - symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234.
77. Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T 1998 Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101:1296-1300.
78. - symporter gene methylation status. J Clin Endocrinol Metab 84:2449-2457.
79. --symporter gene. Endocrinology 138:4493-4496.
80. Mandell RB, Mandell LZ, Link Jr. CJ 1999 Radioisotope concentrator gene therapy using the sodium iodide symporter gene. Cancer Res 59:661-668.
81. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC 1999 Prostate-specific antigen (PSA) promoter-driven and rogen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 59:2136-2141.
82. van Herle AJ, Agatep ML, Padua III DN, Totanes TL, Canlapan DV, van Herle HML, Juillard GJF 1990 Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA RO 82 W-1) in vitro. J Clin Endocrinol Metab 71:755-763.
83. - symporter gene. Biochem Biophys Res Commun 239:34-41.
84. Behr M, Schmitt TL, Espinoza CR, Loos U 1998 Cloning of a functional promoter of the human sodium/iodide-symporter gene. Biochem J 331:359-363.
85. - symporter. J Clin Endocrinol Metab 83:3247-3251.
86. Venkataraman GM, Yatin M, Ain KB 1998 Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid 8:63-69.
87. Schmutzler C, Ohno M, Zannini M, Glaser F, Köhrle J 1999c Differential regulation of the sodium iodide symporter (NIS) by retinoic acid (RA) in the follicular thyroid carcinoma cell line FTC-238 and non-transformed FRTL-5 cells. J Endocrinol Invest 22(Suppl 6): Abstract, p. 128.
88. Bassi V, Vitale M, Feliciello A, De Riu S, Rossi G, Fenzi G 1995 Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines. J Clin Endocrinol Metab 80:1129-1135.
89. Bouillon M, Tessier P, Boulianne R, Destrempe R, Audette M 1991 Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines. Biochim Biophys Acta 1097:95-102.
90. Wang Z, Cao Y, D'Urso CM, Ferrone S 1992 Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression. Cancer Res 52:4766-4776.
91. Rivoltini L, Cattoretti G, Arienti F, Mastroianni A, Melani C, Columbo MP, Parmiani G 1991 The high lysability by LAK cells of colon carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA, and a less differentiated phenotype. Int J Cancer 47:746-754.
92. Stade BG, Messer G, Riethmüller G, Johnson JP 1990 Structural characteristics of the 5′ region of the human ICAM-1 gene. Immunobiology 182:79-87.
93. Bassi V, De Riu S, Feliciello A, Altomonte M, Allevato G, Rossi G, Fenzi G 1998 Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell lines. Thyroid 8:23-28.
94. Pötter E, Bergwitz C, Brabant G 1999 The cadherin-catenin system: Implications for growth and differentiation of endocrine tissues. Endocrine Rev 20:207-239.
95. Brabant G, Hoang-Vu C, Cetin Y, Dralle H, Scheumann G, Mölne J, Hansson G, Jansson S, Ericson LE, Nilsson M 1993 E-Cadherin: A differentiation marker in thyroid malignancies. Cancer Res 53:4987-4993.
96. Hoang-Vu C, Schmutzler C, Schwarz I, Bull K, Aust G, Köhrle J, Dralle H 1998a Effects of retinoic acid on protein expression of CD97 and E-cadherin in the human thyroid carcinoma cell line FTC 133 [abstract]. J Endocrinol Invest 21(Suppl) 4:14.
97. Wei LL, Hui EK, Wei JS, Yung BY 1992 Alkaline phosphatase activity during the differentiation of the human promyelocytic leukemia cell line HL-60. Biochim Biophys Res Commun 182:487-494.
98. Reese DH, Larsen RA, Hornicek FJ 1992 Control of alkaline phosphatase activity in C3H10T1/2 cells: Role of retinoic acid and cell density. J Cell Physiol 151:239-248.
99. Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, Aust G, Köhrle J, Dralle H 1999 Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab 84:1104-1109.
100. Schmutzler C, Schreck R, Bienert K, Köhrle J 1994 Retinoid treatment of thyroid carcinoma cells: A prospect for a redifferentiation therapy? Proceedings EORTC Thyroid Study Group Annual Meeting, Vienna.
101. Hoang-Vu C, Schumann H, Krause G, Bull K, Schwarz I, Goretzki P, Schmutzler C, Köhrle J, Holtz J, Dralle H 1998 Retinoic induced expression of Fas protein in the human thyroid carcinoma cell line FTC-236 [abstract]. Exp Clin Endocr Diab 106(Suppl 1):S83.
102. Simon D, Köhrle J, Schmutzler C, Mainz K, Reiners C, Röher HD 1996 Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results. Exp Clin Endocrinol Metab 104(Suppl 4):13-15.
103. Simon D, Köhrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K, Goretzki PE, Röher HD 1998 Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and papillary thyroid carcinoma. World J Surg 22:569-574.
104. Simon D, Köhrle J, Reiners C, Groth P, Börner AR, Grünwald F, Riccabona G, Mainz K 1998 Redifferentiation therapy in thyroid cancer - Results of a multicenter pilot study [abstract]. Thyroid 8:217.
105. Körber C, Schmutzler C, Rendl J, Koehrle J, Griesser H, Simon D, Reiners C. Increased I-131 uptake in local recurrance and distant metastases after second treatment with retinoic acid. Clin Nucl Med 24:849-851.
106. Ledger GA, Mullan BP, O'Connor MK, et al 1994 Pilot study on the use of 13-cis retinoic acid (isotretinoin) as an adjunct to radioiodine therapy of metastatic thyroid cancer. 76th Annual Meeting of the Endocrine Society; Program and Abstracts, p. 417.
107. Grünwald F, Pakos E, Bender H, Menzel C, Otte R, Palmedo H, Pfeifer U 1998 Redifferentiation therapy with retinoic acid in follicular thyroid cancer. J Nucl Med 39:1555-1558.
108. Grünwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R, Risse J, Biersack HJ 1998 Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 39:1903-1906.
109. Winzer R, Schmutzler C, Jakobs TC, Ebert R, Rendl J, Reiners C, Jakob F, Kohrle J 1998 Reverse transcriptase-polymerase chain reaction analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid [In Process Citation]. Thyroid 8:981-987.
110. Schlumberger M, Baudin E 1998 Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 138:249-252.
111. Feine U 1998 Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer. Eur J Endocrinol 138:492-496.
112. Haugen BR, Pacini FR, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885.
113. - symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131:195-203.
114. Eng P, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-3410.
115. Amphoux-Fazekas T, Samih N, Hovsepian S, Aouani A, Beauwens R, Fayet G 1999 DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid) increases iodide trapping, inhibits thyroperoxidase and antagonizes the TSH-induced apical iodide efflux in porcine thyroid cells. Mol Cell Endocrinol 141:129-140.
116. 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 84:912-916.
117. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski P 1999 The Pendred Syndrome gene encodes a chloride-iodide transport protein. Nat Genet 21:440-443.
118. Nagy L, Thomazy VA, Heyman RA, Davies PJ 1998 Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5:11-19.
119. Teixeira C, Pratt MA 1997 CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 11:1191-1202.
120. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R 1999 Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene 18:2357-2365.
121. Schiller U, Hoffmann W, Bamberg M, Rodemann HP 1997 All-trans-retinoic acid modulates the radiosensitivity of proliferating cells. Int J Cancer 70:488-490.